Related Experiment Video
Updated: Jul 16, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
[Management of chronic viral hepatitis]
Isabelle Pache1, David Mondada, Darius Moradpour
1Service de gastro-entérologie et d'hépatologie, CHUV, 1011 Lausanne. Isabelle.Pache@chuv.ch
Abstract:
This review highlights recent progress in the management of chronic hepatitis B, C and D. New nucleoside and nucleotide analogs have recently been approved and are currently being evaluated for the treatment of chronic hepatitis B. At the same time, resistance is becoming an increasingly common clinical problem. Efforts are currently being made to individualize treatment regimens for patients with chronic hepatitis C, with the aim of enhancing efficacy and improving tolerability. Finally, recent studies using pegylated interferon-alpha have shown promising results for the treatment of chronic hepatitis D.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Chronic Pancreatitis II: Collaborative Care
Assessment:
Inhibitors of Viral Protein Synthesis
Myocarditis IV: Nursing Management
Antiviral Nucleoside Inhibitors
